Neurocrine Biosciences Announces Board Member’s Retirement
Executive Summary
Neurological and endocrine-based diseases specialist Neurocrine Biosciences Inc. has announced that W. Thomas Mitchell will be retiring from the board of directors just prior to the 2016 annual meeting of shareholders. Mitchell has been a member of the board for over 13 years, serving in various capacities on the audit, compensation, nominating and corporate governance committees.